J. L. Juncos
Impact in
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
-
- Neuroscience and Neuropharmacology Research
- Genetic Neurodegenerative Diseases
- Neurotransmitter Receptor Influence on Behavior
Papers in
- Neurology 11
- Parkinson's Disease Mechanisms and Treatments 11
- Neurological disorders and treatments 9
- Neurological diseases and metabolism 1
- Co-authors
- Isabella J.E. Heuser (4 shared papers)Giovanni Fabbrini (7 shared papers)M. Maral Mouradian (7 shared papers)Murray B. Stein (1 shared paper)T W Uhde (1 shared paper)Thomas N. Chase (7 shared papers)Fabio Baronti (2 shared papers)Alan Freeman (2 shared papers)
- Journals
- Neurology (3 papers)Annals of Neurology (2 papers)Annals of the New York Academy of Sciences (1 paper)Clinical Neuropharmacology (1 paper)American Journal of Psychiatry (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
J. L. Juncos
13 papers receiving 630 citations
Peers
Comparison fields: 5 of 61
- Neurology 481
- Cellular and Molecular Neuroscience 184
- Psychiatry and Mental health 95
- Experimental and Cognitive Psychology 60
- Cognitive Neuroscience 78
Countries citing papers authored by J. L. Juncos
This map shows the geographic impact of J. L. Juncos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Juncos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Juncos more than expected).
Fields of papers citing papers by J. L. Juncos
This network shows the impact of papers produced by J. L. Juncos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Juncos. The network helps show where J. L. Juncos may publish in the future.
Co-authors
The 22 scholars most cited alongside J. L. Juncos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 217 | |
| 2 | 1989 | 134 | |
| 3 | Rationale for continuous dopaminomimetic therapy of Parkinson's disease. | 1989 | 123 |
| 4 | 1991 | 53 | |
| 5 | Management of psychotic aspects of Parkinson's disease. | 1999 | 33 |
| 6 | 1987 | 31 | |
| 7 | 1991 | 23 | |
| 8 | 1987 | 17 | |
| 9 | 1988 | 8 | |
| 10 | 1989 | 7 | |
| 11 | 1985 | 5 | |
| 12 | 1989 | 5 | |
| 13 | Motor response complications in advanced Parkinson's disease. | 1989 | 1 |
About J. L. Juncos
J. L. Juncos is a scholar working on Neurology, Cellular and Molecular Neuroscience, Epidemiology, Molecular Biology and Genetics, having authored 13 papers that have together received 657 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (11 papers), Neurological disorders and treatments (9 papers), Restless Legs Syndrome Research (2 papers), Muscle activation and electromyography studies (1 paper), Pharmacological Receptor Mechanisms and Effects (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Receptor Mechanisms and Signaling (1 paper) and Neurological diseases and metabolism (1 paper). The work is most often cited by research in Neurology (481 citations), Cellular and Molecular Neuroscience (184 citations), Psychiatry and Mental health (95 citations), Experimental and Cognitive Psychology (60 citations) and Cognitive Neuroscience (78 citations). J. L. Juncos has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Isabella J.E. Heuser, Giovanni Fabbrini, M. Maral Mouradian, Murray B. Stein, T W Uhde, Thomas N. Chase, Fabio Baronti, Alan Freeman, Ray L. Watts and Nicolas Kahn. Their work appears in journals such as Neurology, Annals of Neurology, Annals of the New York Academy of Sciences, Clinical Neuropharmacology and American Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.